Zusammenfassung
Pathologische Veränderungen der Neurotransmission in der Kochlea, die z. B. durch intensive Lärmbelastung oder ototoxische Substanzen hervorgerufen werden, können zur Entstehung von Tinnitus beitragen. Dabei kommt es an den Schaltstellen zur Veränderung der Effizienz von inhibitorischen und exzitatorischen Neurotransmittern. Glutamat ist der wichtigste afferente Neurotransmitter im Innenohr. Eine massive Glutamatausschüttung als Folge einer Schädigung kann zur Exzitotoxizität und zum irreparablen Zelltod führen. Zu den efferenten Neurotransmittern in der Kochlea zählen Dopamin, γ-Aminobuttersäure (GABA), Acetylcholin (ACH) und Serotonin. Dopamin und GABA sind inhibitorische Transmitter, die vor Glutamatexzitotoxizität schützen. ACH reduziert wie GABA die Steifigkeit der äußeren Haarzellen und führt zu deren Motilitätszunahme. Serotonin ist in der Kochlea ein Neuromodulator der cholinergen und GABA-ergen Innervation und kann glutamaterge Impulse hemmen. Die neuen molekularbiologischen Erkenntnisse über die Neurotransmission in der Kochlea bilden die Grundlage für die Entwicklung neuer Therapieansätze bei Tinnitus. Da es hinsichtlich der Ursachen und der Entstehung verschiedene Formen des Tinnitus gibt, besteht zurzeit die Herausforderung darin, bei den Patienten die individuelle Ursache nachweisen zu können.
Abstract
Pathologic changes in the cochlear neurotransmission, e.g. as a result of intensive noise exposure or ototoxic drugs, can be a factor in the development of tinnitus. The efficiency of inhibitory and excitatory neurotransmitters may then be modulated at the switching points. Glutamate is the most important afferent neurotransmitter within the inner ear. A massive glutamate release induced by cochlear damage may result in excitotoxicity and irrevocable cell death. Efferent cochlear neurotransmitters include dopamine, gammaaminobutyric acid (GABA), acetylcholine (ACH) and serotonin. Dopamine and GABA are inhibitory transmitters that may protect the cochlea from excitotoxicity. ACH, like GABA, reduces the stiffness of the outer hair cells and increases their motility. Serotonin is a neuromodulator of the cholinergic and GABAergic innervation within the cochlea and can inhibit glutamatergic impulses. Our understanding of neurotransmission in the cochlea has been extended by advances in molecular biology, which has given rise to new approaches in the treatment of tinnitus. As there are several types of tinnitus, differing in aetiology and development, our present challenge is to achieve precise identification of the cause in individual cases of tinnitus.
Literatur
Arnold T, Oestreicher E, Ehrenberger K, Felix D (1998) GABA(A) receptor modulates the activity of inner hair cell afferents in guinea pig cochlea. Hear Res 125: 147–153
Ashmore J (2002) Biophysics of the cochlea – biomechanics and ion channelopathies. Br Med Bull 63: 59–72
Baldo P, Doree C, Lazzarini R et al. (2006) Antidepressants for patients with tinnitus. Cochrane Database Syst Rev 4: CD003853
Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38: 1083–1152
Batta TJ, Panyi G, Szucs A, Sziklai I (2004) Regulation of the lateral wall stiffness by acetylcholine and GABA in the outer hair cells of the guinea pig. Eur J Neurosci 20: 3364–3370
Bauer CA, Brozoski TJ (2006) Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope 116: 675–681
Bustos G, Abarca J, Campusano J et al. (2004) Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain. Brain Res Brain Res Rev 47: 126–144
Caspary DM, Holder TM, Hughes LF et al. (1999) Age-related changes in GABA(A) receptor subunit composition and function in rat auditory system. Neuroscience 93: 307–312
Chen C, Bobbin RP (1998) P2X receptors in cochlear Deiters‘ cells. Br J Pharmacol 124: 337–344
Chen Z, Ulfendahl M, Ruan R et al. (2004) Protection of auditory function against noise trauma with local caroverine administration in guinea pigs. Hear Res 197: 131–136
Claussen E, Claussen CF, Patil NP (1988) On the effect of magnesium-aspartate in the neurootological therapy for vertigo and tinnitus. In: Claussen CF, Kitane MV, Schlitter N (eds) Vertigo, nausea, tinnitus and hyperacusia in metabolic disorders. Excerpta Medica, Amsterdam, pp 529–532
Cransac H, Peyrin L, Cottet-Emard JM et al. (1996) Aging effects on monoamines in rat medial vestibular and cochlear nuclei. Hear Res 100: 150–156
Cung DD, Stimmel GL (1997) Reemergence of positive symptoms after initial response to risperidone. Pharmacotherapy 17: 383–386
d’Aldin C, Puel JL, Leducq R et al. (1995) Effects of a dopaminergic agonist in the guinea pig cochlea. Hear Res 90: 202–211
Dallos P, He DZ, Lin X et al. (1997) Acetylcholine, outer hair cell electromotility, and the cochlear amplifier. J Neurosci 17: 2212–2226
Darrow KN, Simons EJ, Dodds L, Liberman MC (2006) Dopaminergic innervation of the mouse inner ear: evidence for a separate cytochemical group of cochlear efferent fibers. J Comp Neurol 498: 403–414
Denk DM, Ehrenberger K (1992) Tinnitus: causes, diagnosis, therapy. Wien Med Wochenschr 142: 259–262
Denk DM, Heinzl H, Franz P, Ehrenberger K (1997) Caroverine in tinnitus treatment. A placebo-controlled blind study. Acta Otolaryngol 117: 825–830
Ditzler K (1991) Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial. Arzneimittelforschung 41: 773–780
Doleviczenyi Z, Halmos G, Repassy G et al. (2005) Cochlear dopamine release is modulated by group II metabotropic glutamate receptors via GABAergic neurotransmission. Neurosci Lett 385: 93–98
Domeisen H, Hotz MA, Hausler R (1998) Caroverine in tinnitus treatment. Acta Otolaryngol 118: 606–608
Eggermont JJ (2005) Tinnitus: neurobiological substrates. Drug Discov Today 10: 1283–1290
Ehrenberger K, Denk D-M, Felix D (1995) Rezeptorpharmakologische Modelle für eine kausale Tinnitustherapie. Otorhinolaryngol Nova 5: 148–152
Elgoyhen AB, Vetter DE, Katz E et al. (2001) alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc Natl Acad Sci U S A 98: 3501–3506
Eybalin M (1993) Neurotransmitters and neuromodulators of the mammalian cochlea. Physiol Rev 73: 309–373
Eybalin M, Parnaud C, Geffard M, Pujol R (1988) Immunoelectron microscopy identifies several types of GABA-containing efferent synapses in the guinea-pig organ of Corti. Neuroscience 24: 29–38
Eybalin M, Pujol R (1984) Immunofluorescence with Met-enkephalin and Leu-enkephalin antibodies in the guinea pig cochlea. Hear Res 13: 135–140
Eybalin M, Pujol R (1987) Choline acetyltransferase (ChAT) immunoelectron microscopy distinguishes at least three types of efferent synapses in the organ of Corti. Exp Brain Res 65: 261–270
Felix D, Ehrenberger K (1992) The efferent modulation of mammalian inner hair cell afferents. Hear Res 64: 1–5
Fessenden JD, Schacht J (1998) The nitric oxide/cyclic GMP pathway: a potential major regulator of cochlear physiology. Hear Res 118: 168–176
Fex J, Altschuler RA (1984) Glutamic acid decarboxylase immunoreactivity of olivocochlear neurons in the organ of Corti of guinea pig and rat. Hear Res 15: 123–131
Fex J, Altschuler RA, Kachar B et al. (1986) GABA visualized by immunocytochemistry in the guinea pig cochlea in axons and endings of efferent neurons. Brain Res 366: 106–117
Fischer PA, Jacobi P, Schneider E, Schonberger B (1977) Effects of intravenous administration of memantine in parkinsonian patients. Arzneimittelforschung 27: 1487–1489
Furness DN, Lawton DM (2003) Comparative distribution of glutamate transporters and receptors in relation to afferent innervation density in the mammalian cochlea. J Neurosci 23: 11296–11304
Furness DN, Lehre KP (1997) Immunocytochemical localization of a high-affinity glutamate-aspartate transporter, GLAST, in the rat and guinea-pig cochlea. Eur J Neurosci 9: 1961–1969
Gananca MM, Caovilla HH, Gananca FF et al. (2002) Clonazepam in the pharmacological treatment of vertigo and tinnitus. Int Tinnitus J 8: 50–53
Geisler CD (1998) From sound to synapse. Oxford University Press, New York
Gil-Loyzaga P, Bartolome V, Vicente-Torres A, Carricondo F (2000) Serotonergic innervation of the organ of Corti. Acta Otolaryngol 120: 128–132
Guitton MJ, Wang J, Puel JL (2004) New pharmacological strategies to restore hearing and treat tinnitus. Acta Otolaryngol 124: 411–415
Hakuba N, Koga K, Gyo K et al. (2000) Exacerbation of noise-induced hearing loss in mice lacking the glutamate transporter GLAST. J Neurosci 20: 8750–8753
Halmos G, Lendvai B, Gaborjan A et al. (2002) Simultaneous measurement of glutamate and dopamine release from isolated guinea pig cochlea. Neurochem Int 40: 243–248
Hastak SM (2003) Treatment of memory impairment, vertigo and tinnitus in the elderly with piribedil in an Indian general practice setting. J Indian Med Assoc 101: 500–501
Herrera AJ, Machado A, Cano J (1991) The influence of age on neurotransmitter turnover in the rat’s superior colliculus. Neurobiol Aging 12: 289–294
Hoffman DW, Zamir N, Rubio JA et al. (1985) Proenkephalin and prodynorphin related neuropeptides in the cochlea. Hear Res 17: 47–50
Holmes C, Arranz MJ, Powell JF et al. (1998) 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer’s disease. Hum Mol Genet 7: 1507–1509
Housley GD, Kanjhan R, Raybould NP et al. (1999) Expression of the P2X(2) receptor subunit of the ATP-gated ion channel in the cochlea: implications for sound transduction and auditory neurotransmission. J Neurosci 19: 8377–8388
Inoue T, Matsubara A, Maruya S et al. (2006) Localization of dopamine receptor subtypes in the rat spiral ganglion. Neurosci Lett 399: 226–229
Joachims Z, Netzer A, Ising H et al. (1993) Oral magnesium supplementation as prophylaxis for noise-induced hearing loss: results of a double blind field study. Schriftenr Ver Wasser Boden Lufthyg 88: 503–516
Johnson RM, Brummett R, Schleuning A (1993) Use of alprazolam for relief of tinnitus. A double-blind study. Arch Otolaryngol Head Neck Surg 119: 842–845
Klinke R (1986) Neurotransmission in the inner ear. Hear Res 22: 235–243
Koyano K, Ohmori H (1996) Cellular approach to auditory signal transmission. Jpn J Physiol 46: 289–310
Kuriyama H, Albin RL, Altschuler RA (1993) Expression of NMDA-receptor mRNA in the rat cochlea. Hear Res 69: 215–220
Kuriyama H, Jenkins O, Altschuler RA (1994) Immunocytochemical localization of AMPA selective glutamate receptor subunits in the rat cochlea. Hear Res 80: 233–240
Lin X, Chen S, Chen P (2000) Activation of metabotropic GABAB receptors inhibited glutamate responses in spiral ganglion neurons of mice. Neuroreport 11: 957–961
Lopez-Gonzalez MA, Muratori Leon ML, Moreno VJ (2003) Sulpiride as initial treatment in tinnitus retraining therapy. Acta Otorrinolaringol Esp 54: 237–241
Lustig LR (2006) Nicotinic acetylcholine receptor structure and function in the efferent auditory system. Anat Rec A Discov Mol Cell Evol Biol 288: 424–434
Maison SF, Rosahl TW, Homanics GE, Liberman MC (2006) Functional role of GABAergic innervation of the cochlea: phenotypic analysis of mice lacking GABA(A) receptor subunits alpha 1, alpha 2, alpha 5, alpha 6, beta 2, beta 3, or delta. J Neurosci 26: 10315–10326
Malgrange B, Rigo JM, Lefebvre PP et al. (1997) Diazepam-insensitive GABAA receptors on postnatal spiral ganglion neurones in culture. Neuroreport 8: 591–596
Matsubara A, Laake JH, Davanger S et al. (1996) Organization of AMPA receptor subunits at a glutamate synapse: a quantitative immunogold analysis of hair cell synapses in the rat organ of Corti. J Neurosci 16: 4457–4467
Mazurek B, Haupt H, Gross J (2006) Pharmakotherapie des akuten Tinnitus unter besonderer Berücksichtigung der Rolle von Hypoxie und Ischämie bei der Tinnitusentstehung. HNO 54: 9–15
Meyer J, Gummer AW (2000) Physiological effects of destruction of the tip links of cochlear hair cells. Significance for noise-induced hearing loss. HNO 48: 383–389
Moller AR (2006) Hearing: anatomy, physiology, and disorders of the auditory system. 2nd edn. Academic Press, Amsterdam
Mukherjee J, Christian BT, Dunigan KA et al. (2002) Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse 46: 170–188
Niedzielski AS, Safieddine S, Wenthold RJ (1997) Molecular analysis of excitatory amino acid receptor expression in the cochlea. Audiol Neurootol 2: 79–91
Niu X, Canlon B (2006) The signal transduction pathway for the dopamine D1 receptor in the guinea-pig cochlea. Neuroscience 137: 981–990
Nordang L, Oestreicher E, Arnold W, Anniko M (2000) Glutamate is the afferent neurotransmitter in the human cochlea. Acta Otolaryngol 120: 359–362
Oestreicher E, Arnold W, Barun S (2004) Die lokale Applikation von Memantine inhibiert Salizylat induzierten Tinnitus. Abstract, 75. Jahresversammlung der dt. Ges. f. Hals-Nasan-Ohren-Heilkunde, Kopf- und Hals-Chirurgie, 19.–23.Mai, Bad Reichenhall
Oestreicher E, Arnold W, Ehrenberger K, Felix D (1997) Dopamine regulates the glutamatergic inner hair cell activity in guinea pigs. Hear Res 107: 46–52
Oestreicher E, Arnold W, Ehrenberger K, Felix D (1998) Memantine suppresses the glutamatergic neurotransmission of mammalian inner hair cells. ORL J Otorhinolaryngol Relat Spec 60: 18–21
Oliveira JR, Zatz M (1999) The study of genetic polymorphisms related to serotonin in Alzheimer’s disease: a new perspective in a heterogenic disorder. Braz J Med Biol Res 32: 463–467
Ottersen OP, Takumi Y, Matsubara A et al. (1998) Molecular organization of a type of peripheral glutamate synapse: the afferent synapses of hair cells in the inner ear. Prog Neurobiol 54: 127–148
Puel JL (1995) Chemical synaptic transmission in the cochlea. Prog Neurobiol 47: 449–476
Puel JL, Ruel J, Guitton M et al. (2002) The inner hair cell synaptic complex: physiology, pharmacology and new therapeutic strategies. Audiol Neurootol 7: 49–54
Puel JL, Saffiedine S, Gervais d‘ Aldin C et al. (1995) Synaptic regeneration and functional recovery after excitotoxic injury in the guinea pig cochlea. C R Acad Sci III 318: 67–75
Raphael Y, Altschuler RA (2003) Structure and innervation of the cochlea. Brain Res Bull 60: 397–422
Rebillard G, Ruel J, Nouvian R et al. (2003) Glutamate transporters in the guinea-pig cochlea: partial mRNA sequences, cellular expression and functional implications. Eur J Neurosci 17: 83–92
Robertson D, Johnstone BM (1978) Efferent transmitter substance in the mammalian cochlea: single neuron support for acetylcholine. Hear Res 1: 31–34
Robinson SK, Viirre ES, Bailey KA et al. (2005) Randomized placebo-controlled trial of a selective serotonin reuptake inhibitor in the treatment of nondepressed tinnitus subjects. Psychosom Med 67: 981–988
Rothlin CV, Lioudyno MI, Silbering AF et al. (2003) Direct interaction of serotonin type 3 receptor ligands with recombinant and native alpha 9 alpha 10-containing nicotinic cholinergic receptors. Mol Pharmacol 63: 1067–1074
Ruel J, Chen C, Pujol R et al. (1999) AMPA-preferring glutamate receptors in cochlear physiology of adult guinea-pig. J Physiol 518: 667–680
Ruel J, Nouvian R, Gervais d‘ Aldin C et al. (2001) Dopamine inhibition of auditory nerve activity in the adult mammalian cochlea. Eur J Neurosci 14: 977–986
Ruel J, Wang J, Rebillard G et al. (2007) Physiology, pharmacology and plasticity at the inner hair cell synaptic complex. Hear Res 227: 19–27
Ryan AF, Brumm D, Kraft M (1991) Occurrence and distribution of non-NMDA glutamate receptor mRNAs in the cochlea. Neuroreport 2: 643–646
Safieddine S, Eybalin M (1992) Co-expression of NMDA and AMPA/kainate receptor mRNAs in cochlear neurones. Neuroreport 3: 1145–1148
Safieddine S, Eybalin M (1995) Expression of mGluR1 alpha mRNA receptor in rat and guinea pig cochlear neurons. Neuroreport 7: 193–196
Salvinelli F, Casale M, Paparo F et al. (2003) Subjective tinnitus, temporomandibular joint dysfunction, and serotonin modulation of neural plasticity: causal or casual triad? Med Hypotheses 61: 446–448
Shemen L (1998) Fluoxetine for treatment of tinnitus. Otolaryngol Head Neck Surg 118: 421
Shimizu I, Prasad C (1991) Relationship between [3H]mazindol binding to dopamine uptake sites and [3H]dopamine uptake in rat striatum during aging. J Neurochem 56: 575–579
Shulman A, Strashun AM, Goldstein BA (2002) GABAA-benzodiazepine-chloride receptor-targeted therapy for tinnitus control: preliminary report. Int Tinnitus J 8: 30–36
Shulman A, Strashun AM, Seibyl JP et al. (2000) Benzodiazepine receptor deficiency and tinnitus. Int Tinnitus J 6: 98–111
Simmons DD (2002) Development of the inner ear efferent system across vertebrate species. J Neurobiol 53: 228–250
Simmons DD, Morley BJ (1998) Differential expression of the alpha 9 nicotinic acetylcholine receptor subunit in neonatal and adult cochlear hair cells. Brain Res Mol Brain Res 56: 287–292
Simpson JJ, Davies WE (2000) A review of evidence in support of a role for 5-HT in the perception of tinnitus. Hear Res 145: 1–7
Spoendlin H (1994) Strukturelle Organisation des Innenohres. In: Helms J (Hrsg) Oto-Rhino-Laryngologie in Klinik und Praxis, Bd 1: Ohr. Thieme, Stuttgart, S 32–81
Sziklai I, Szonyi M, Dallos P (2001) Phosphorylation mediates the influence of acetylcholine upon outer hair cell electromotility. Acta Otolaryngol 121: 153–156
Usami S, Hozawa J, Tazawa M et al. (1988) Immunocytochemical study of catecholaminergic innervation in the guinea pig cochlea. Acta Otolaryngol Suppl 447: 36–45
Venero JL, De la Roza C, Machado A, Cano J (1993) Age-related changes on monoamine turnover in hippocampus of rats. Brain Res 631: 89–96
Venero JL, Machado A, Cano J (1991) Age effects on monoamine turnover of the rat substantia nigra. Brain Res 557: 109–114
Vicente-Torres MA, Davila D, Bartolome MV et al. (2003) Biochemical evidence for the presence of serotonin transporters in the rat cochlea. Hear Res 182: 43–47
Warr WB (1975) Olivocochlear and vestibular efferent neurons of the feline brain stem: their location, morphology and number determined by retrograde axonal transport and acetylcholinesterase histochemistry. J Comp Neurol 161: 159–181
Westerberg BD, Roberson JB Jr, Stach BA (1996) A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus. Am J Otolaryngol 17: 896–903
Zapp JJ (2001) Gabapentin for the treatment of tinnitus: a case report. Ear Nose Throat J 80: 114–116
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mazurek, B., Stöver, T., Haupt, H. et al. Die Rolle der kochleären Neurotransmitter in Bezug auf Tinnitus. HNO 55, 964–971 (2007). https://doi.org/10.1007/s00106-007-1624-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00106-007-1624-7